Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd researches and develops, produces, and sells Chinese patent medicines in China. It offers orthopedic, cardiovascular, cerebrovascular, digestive, respiratory, pediatrics, gynecology, hepatobiliary, rheumatism and bone injury, tonic, heat-clearing and detoxifying, and liver and gallbladder drugs, as well as supplements and traditional Chine… Read more
Market Cap & Net Worth: Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (002864)
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A (SHE:002864) has a market capitalization of $482.93 Million (CN¥3.54 Billion) as of March 18, 2026. Listed on the SHE stock exchange, this China-based company holds position #12894 globally and #3248 in its home market, demonstrating a -1.59% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's stock price CN¥33.34 by its total outstanding shares 106280960 (106.28 Million).
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Market Cap History: 2017 to 2026
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market capitalization history from 2017 to 2026. Data shows growth from $401.31 Million to $482.93 Million (11.00% CAGR).
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.45x
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market cap is 0.45 times its annual revenue
1.02x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
3.66x
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market cap is 3.66 times its annual earnings
10.35x
Lower than industry averageWhat These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2017 | $401.31 Million | $376.79 Million | $43.72 Million | 1.07x | 9.18x |
| 2018 | $447.72 Million | $489.45 Million | $64.68 Million | 0.91x | 6.92x |
| 2019 | $386.88 Million | $610.64 Million | $71.78 Million | 0.63x | 5.39x |
| 2020 | $355.53 Million | $670.31 Million | $79.11 Million | 0.53x | 4.49x |
| 2021 | $446.22 Million | $887.48 Million | $93.17 Million | 0.50x | 4.79x |
| 2022 | $555.32 Million | $974.29 Million | $101.16 Million | 0.57x | 5.49x |
| 2023 | $553.33 Million | $980.83 Million | $110.43 Million | 0.56x | 5.01x |
| 2024 | $440.49 Million | $973.86 Million | $120.27 Million | 0.45x | 3.66x |
Competitor Companies of 002864 by Market Capitalization
Companies near Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A in the global market cap rankings as of March 18, 2026.
Key companies related to Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A by market ranking:
- Zoetis Inc (NYSE:ZTS): Ranked #410 globally with a market cap of $53.52 Billion USD.
- Haleon plc (NYSE:HLN): Ranked #434 globally with a market cap of $49.87 Billion USD.
- Takeda Pharmaceutical Co. Ltd. (PINK:TKPHF): Ranked #457 globally with a market cap of $47.47 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #721 globally with a market cap of $28.19 Billion USD ( CN¥206.84 Billion CNY).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #410 | Zoetis Inc | NYSE:ZTS | $53.52 Billion | $121.68 |
| #434 | Haleon plc | NYSE:HLN | $49.87 Billion | $10.60 |
| #457 | Takeda Pharmaceutical Co. Ltd. | PINK:TKPHF | $47.47 Billion | $30.07 |
| #721 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $28.19 Billion | CN¥55.11 |
Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A Historical Marketcap From 2017 to 2026
Between 2017 and today, Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A's market cap moved from $401.31 Million to $ 482.93 Million, with a yearly change of 11.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | CN¥482.93 Million | +8.11% |
| 2025 | CN¥446.72 Million | +1.41% |
| 2024 | CN¥440.49 Million | -20.39% |
| 2023 | CN¥553.33 Million | -0.36% |
| 2022 | CN¥555.32 Million | +24.45% |
| 2021 | CN¥446.22 Million | +25.51% |
| 2020 | CN¥355.53 Million | -8.10% |
| 2019 | CN¥386.88 Million | -13.59% |
| 2018 | CN¥447.72 Million | +11.56% |
| 2017 | CN¥401.31 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 18th, 2026 the market cap of Shaanxi Panlong Pharmaceutical Group Limited By Share Ltd Class A was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $482.93 Million USD |
| MoneyControl | $482.93 Million USD |
| MarketWatch | $482.93 Million USD |
| marketcap.company | $482.93 Million USD |
| Reuters | $482.93 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.